Trades Apr 25, 2023 – Nov 5, 2025

Issuer

CRLCharles River Laboratories International, Inc.

4 politicians disclosed trades in CRL (Charles River Laboratories International, Inc.) between Apr 25, 2023 – Nov 5, 2025.

Trades

5

Politicians

4

Buy vol.

$24.0k

Sell vol.

$16.0k

Who disclosed trades in CRL

A sale may close the position; filings are not a live holdings snapshot.

Representatives who traded CRL (3)

NameLast tradeBuysSellsEst. volume
Lois FrankelSep 8, 202311$16.0k
Julie JohnsonJan 15, 202510$8,001
Rob BresnahanMay 15, 202501$8,001

Democrats who traded CRL (2)

NameLast tradeBuysSellsEst. volume
Lois FrankelSep 8, 202311$16.0k
Julie JohnsonJan 15, 202510$8,001

Republicans who traded CRL (2)

NameLast tradeBuysSellsEst. volume
Donald J. TrumpNov 5, 202510$8,001
Rob BresnahanMay 15, 202501$8,001

Recent trades (5)

PoliticianTraded issuerSectorTypeSizeTraded
Trade price
Yesterday
PublishedFiled after
Donald J. Trump
Charles River Laboratories International, Inc.CRL
HealthcarePurchase$1k–$15kNov 5, 2025
$167.70
$295.96
Nov 5, 2025—
Rob Bresnahan
Charles River Laboratories International, Inc.CRL
HealthcareSale$1k–$15kMay 15, 2025
$138.89
$295.96
May 31, 202516 days
Julie Johnson
Charles River Laboratories International, Inc.CRL
HealthcarePurchase$1k–$15kJan 15, 2025
$173.91
$295.96
Feb 12, 202528 days
Lois Frankel
Charles River Laboratories International, Inc.CRL
HealthcareSale$1k–$15kSep 8, 2023
$199.74
$295.96
Oct 10, 202332 days
Lois Frankel
Charles River Laboratories International, Inc.CRL
HealthcarePurchase$1k–$15kApr 25, 2023
$187.60
$295.96
May 19, 202324 days

Download CRL congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.

RSS for CRLNew congressional filings in this symbol, by filing date.

Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.